(Q40454217)

English

Adenosine deaminase (ADA) deficiency in cells derived from humans with severe combined immunodeficiency is due to an aberration of the ADA protein.

scientific article published on January 1984

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

20 September 2017

Adenosine deaminase (ADA) deficiency in cells derived from humans with severe combined immunodeficiency is due to an aberration of the ADA protein. (English)

1 reference

Europe PubMed Central

PMC publication ID

20 September 2017

severe combined immunodeficiency

1 reference

based on heuristic

inferred from title

author name string

Valerio D

1

1 reference

Europe PubMed Central

PMC publication ID

20 September 2017

Duyvesteyn MG

2

1 reference

Europe PubMed Central

PMC publication ID

20 September 2017

van Ormondt H

3

1 reference

Europe PubMed Central

PMC publication ID

20 September 2017

Meera Khan P

4

1 reference

Europe PubMed Central

PMC publication ID

20 September 2017

van der Eb AJ

5

1 reference

Europe PubMed Central

PMC publication ID

20 September 2017

publication date

1 January 1984

1 reference

Europe PubMed Central

PMC publication ID

20 September 2017

Nucleic Acids Research

1 reference

Europe PubMed Central

PMC publication ID

20 September 2017

12

1 reference

Europe PubMed Central

PMC publication ID

20 September 2017

2

1 reference

Europe PubMed Central

PMC publication ID

20 September 2017

1015-1024

1 reference

Europe PubMed Central

PMC publication ID

20 September 2017

Biochemistry of Diseases of Immunodevelopment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=318552

22 September 2017

Adenosine Deaminase Deficiency and Severe Combined Immunodeficiency Disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=318552

22 September 2017

Adenosine deaminase messenger RNAs in lymphoblast cell lines derived from leukemic patients and patients with hereditary adenosine deaminase deficiency

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=318552

22 September 2017

Characterization of residual enzyme activity in fibroblasts from patients with adenosine deaminase deficiency and combined immunodeficiency: evidence for a mutant enzyme

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=318552

22 September 2017

Erythrocyte adenosine deaminase deficiency without immunodeficiency. Evidence for an unstable mutant enzyme

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=318552

22 September 2017

Human adenosine deaminase. Purification and subunit structure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=318552

22 September 2017

Immunoreactive protein in adenosine deaminase deficient human lymphoblast cell lines.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=318552

17 June 2018

Characteristics of an aminohydrolase distinct from adenosine deaminase in cultured human lymphoblasts

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=318552

17 June 2018

Characterization of cells transformed by Ad5/Ad12 hybrid early region I plasmids.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=318552

20 August 2018

Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity

1 reference

https://pubmed.ncbi.nlm.nih.gov/6198631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human adenosine deaminase. Properties and turnover in cultured T and B lymphoblasts

1 reference

https://pubmed.ncbi.nlm.nih.gov/6198631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Basic defect in the expression of adenosine deaminase in ADA-SCID disease. II. Deficiency of ADA-CRM detected in heterozygote human-Chinese hamster cell hybrids

1 reference

https://pubmed.ncbi.nlm.nih.gov/6198631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phenotypically normal revertant of an adenosine deaminase-deficient lymphoblast cell line

1 reference

https://pubmed.ncbi.nlm.nih.gov/6198631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1093/NAR/12.2.1015

1 reference

Europe PubMed Central

PMC publication ID

20 September 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40454217&oldid=1493987314"